fig1
From: The arsenic trioxide paradox: a targeted therapy triumph in APL versus a metabolic bottleneck beyond
Figure 1. Arsenic trioxide (ATO) research and development journey: from poison to precision therapy.
Navigation
Figure 1. Arsenic trioxide (ATO) research and development journey: from poison to precision therapy.
